LIGAND PHARMACEUTICALS INC
LGND
40 insider filings · Latest: Oct 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Jun 10 8:45 PM | Aryeh Jason | Proposed Sale | 500 | $249.96 | $125.0K | — | View → |
| Jun 10, 2026 | Jun 10 8:07 PM | JOHN L LAMATTINA | Proposed Sale | 4,519 | $250.88 | $1.1M | — | View → |
| Jun 10, 2026 | Jun 10 5:41 PM | Aryeh Jason | Proposed Sale | 5,000 | $249.35 | $1.2M | — | View → |
| Jun 1, 2026 | Jun 2 10:22 PM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $227.06 | $1.1M | 41,382(D) | View → |
| May 13, 2026 | May 15 1:08 AM | John W KozarichDirector | Sale | 1,575 | $223.50 | $352.0K | 41,786(D) | View → |
| May 12, 2026 | May 15 1:08 AM | John W KozarichDirector | Sale | 459 | $224.00 | $102.8K | 41,786(D) | View → |
| May 1, 2026 | May 15 1:08 AM | John W KozarichDirector | Sale | 467 | $231.80 | $108.3K | 41,786(D) | View → |
| May 13, 2026 | May 13 8:09 PM | JOHN KOZARICH | Proposed Sale | 1,575 | $223.50 | $352.0K | — | View → |
| May 12, 2026 | May 12 9:45 PM | JOHN KOZARICH | Proposed Sale | 459 | $224.00 | $102.8K | — | View → |
| May 1, 2026 | May 5 12:20 AM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $231.31 | $1.2M | 41,382(D) | View → |
| May 1, 2026 | May 1 8:16 PM | KOZARICH JOHN W | Proposed Sale | 467 | $229.87 | $107.3K | — | View → |
| Apr 1, 2026 | Apr 2 11:43 PM | John W KozarichDirector | Sale | 467 | $202.23 | $94.4K | 42,253(D) | View → |
| Apr 1, 2026 | Apr 2 10:56 PM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $201.24 | $1.0M | 41,382(D) | View → |
| Apr 1, 2026 | Apr 1 8:10 PM | KOZARICH JOHN W | Proposed Sale | 467 | $203.50 | $95.0K | — | View → |
| Mar 6, 2026 | Mar 31 9:53 PM | John L LamattinaDirector | Sale | 2,161 | $200.76 | $433.8K | 30,724(D) | View → |
| Mar 23, 2026 | Mar 25 3:13 PM | Stephen L SabbaDirector | Sale | 1,000 | $207.87 | $207.9K | 32,793(D) | View → |
| Mar 23, 2026 | Mar 23 8:04 PM | STEPHEN L. SABBA | Proposed Sale | 1,000 | $207.87 | $207.9K | — | View → |
| Mar 11, 2026 | Mar 13 11:29 PM | Octavio EspinozaChief Financial Officer | Sale | 3,057 | $225.00 | $687.8K | 21,010(D) | View → |
| Mar 11, 2026 | Mar 11 8:42 PM | OCTAVIO ESPINOZA | Proposed Sale | 3,057 | $212.29 | $649.0K | — | View → |
| Mar 4, 2026 | Mar 6 11:51 PM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $206.35 | $1.0M | 36,869(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Mar 31 9:53 PM | John L LamattinaDirector | Option Exercise | 2,161 | $114.15 | 0(D) | View → |
| Mar 2, 2026 | Mar 28 1:20 AM | Octavio EspinozaChief Financial Officer | Grant/Award | 23,527 | $202.55 | 23,527(D) | View → |
| Mar 2, 2026 | Mar 28 12:33 AM | Todd C DavisDirector, Chief Executive Officer | Grant/Award | 50,058 | $202.55 | 50,058(D) | View → |
| Mar 2, 2026 | Mar 28 12:16 AM | Andrew ReardonCLO & Secretary | Grant/Award | 21,525 | $202.55 | 21,525(D) | View → |
| Mar 11, 2026 | Mar 13 11:29 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,405 | $92.65 | 0(D) | View → |
| Mar 4, 2026 | Mar 6 11:51 PM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 54,444(D) | View → |
| Mar 4, 2026 | Mar 6 11:49 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,073 | $80.72 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 4:05 PM | Stephen L SabbaDirector | Option Exercise | 2,034 | $69.51 | 0(D) | View → |
← Previous
Page 2 of 2